期刊文献+

盐酸奥昔布宁贴剂的制备及质量评价 被引量:1

Preparation of Oxybutynin Transdermal Patch and Quality Evaluation in vitro
下载PDF
导出
摘要 目的制备盐酸奥昔布宁透皮贴剂,并对其质量进行评价。方法以丙烯酸树脂为基质材料,制备奥昔布宁贴剂,采用.HPLC法测定贴剂中药物含量;采用改良Franz扩散池法,考察贴剂的经皮渗透速率;采用《中国药典》附录法考察贴剂的体外释放行为和黏附性能。结果奥昔布宁贴剂体外72 h释药可达85%以上,其透皮稳态流量为8.01μg·(cm^2·h)^(-1),并可维持3~4 d的零级透皮速率,初黏力钢球号在16~18之间,持黏力在30~35 min之间。结论自制盐酸奥昔布宁贴剂基本达到国外上市药品质量标准。 Objective To prepare the oxybutynin transdermal patch and to study its quality. Methods The oxybutynin patch was prepared using polymethyl methacrylate as the vehicle. An HPLC method was established to determine the concentration of oxybutynin in vitro. Oxybutynin across the mouse skin was studied with Franz diffusion cell. Adhesion properties were evaluated by means of creep resistance test and rolling ball test. Results The cumulative release of oxybutynin from the patch was over 85%. The permeation kinetics of oxybutynin across the mouse skin showed a zero-order pattern. The J of the patch was 8.01 μg ·( cm^2·h) ^-1. The peel adhesion and creep resistance were equal to No. 18 steel ball and 30 min repectively. Conclusion The prepared oxybutynin transdermal patch shows as good quality as foreign ones.
出处 《解放军药学学报》 CAS CSCD 2015年第2期130-132,共3页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 奥昔布宁 贴剂 HPLC oxybutynin transdermal patch HPLC
  • 相关文献

参考文献4

  • 1Cartwright R, Cardozo L. Transdermal oxybutynin: sticking to the facts[J]. European urology,2007,51 (4) :907 -914.
  • 2Baldwin CM, Keating GM. Transdermal oxybutynin [ J ]. Drugs, 2009,69 (3) :327 - 337.
  • 3Nicoli S, Penna E, Padula C, et al. New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin [ J ]. International journal of pharmaceutics, 2006,325 ( 1-2 ) : 2-7.
  • 4仓惠,任丽莉,陈国广,刘雅娟.奥昔布宁透皮贴剂的制备及其体外透皮性研究[J].中国药房,2013,24(45):4250-4252. 被引量:2

二级参考文献7

  • 1陈西良,任明华,倪少滨.膀胱过度活动症治疗进展[J].中华临床医师杂志(电子版),2011,5(13):3856-3859. 被引量:9
  • 2韩璐,胡晋红,朱全刚.经皮给药系统促渗方法研究的新进展[J].中国新药杂志,2007,16(4):274-278. 被引量:9
  • 3Cartwright R, Cardozo L. Transdermal oxybutynin: stick- ing to the facts[J]. Eur Urol, 2007,51 (4) : 907.
  • 4Howard R, Schmid B, Feick A, et al. Oxybutynin enantio- mer pharmaceutics following oral and transdermal deliv- eIy[J].Pharmaceutical Research, 2001,18 (7) : 1 029.
  • 5McCrery ILl, Appell RA. Oxybutynin: an overview of the available formulations[J]. Therapeutics and Clinical Risk Management, 2006,2 ( 1 ) : 19.
  • 6罗静.洛索洛芬钠巴布剂的制备及质量评价[D].重庆:重庆医科大学.2012:25-50.
  • 7温清,郭瑞臣,温绪东,王本杰.奥昔布宁凝胶剂的制备和体外释药特性[J].山东大学学报(医学版),2004,42(2):235-237. 被引量:2

共引文献1

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部